CMRX

Chimerix (CMRX)

Chimerix Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CMRX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/02/01	06 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CMRX	Chimerix Inc
2025/02/01	06 : 39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CMRX	Chimerix Inc
2025/02/01	06 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CMRX	Chimerix Inc
2025/01/31	03 : 00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CMRX	Chimerix Inc
2025/01/31	03 : 00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CMRX	Chimerix Inc
2025/01/31	03 : 00	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:CMRX	Chimerix Inc
2025/01/30	06 : 15	GlobeNewswire Inc.	Chimerix to Present at JonesTrading Virtual Precision Medicine Symposium	NASDAQ:CMRX	Chimerix Inc
2025/01/25	06 : 01	GlobeNewswire Inc.	Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:CMRX	Chimerix Inc
2025/01/13	21 : 00	GlobeNewswire Inc.	Chimerix to Speak Today at The White House Cancer Moonshot Forum	NASDAQ:CMRX	Chimerix Inc
2025/01/11	05 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CMRX	Chimerix Inc
2025/01/11	05 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CMRX	Chimerix Inc
2025/01/11	04 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CMRX	Chimerix Inc
2025/01/11	04 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CMRX	Chimerix Inc
2025/01/11	04 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CMRX	Chimerix Inc
2025/01/11	04 : 57	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CMRX	Chimerix Inc
2024/12/30	21 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CMRX	Chimerix Inc
2024/12/30	21 : 00	GlobeNewswire Inc.	Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma	NASDAQ:CMRX	Chimerix Inc
2024/12/10	23 : 55	AllPennyStocks.com	Small Cap Soars On FDA Submission Plans	NASDAQ:CMRX	Chimerix Inc
2024/12/10	22 : 49	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CMRX	Chimerix Inc
2024/12/10	06 : 01	GlobeNewswire Inc.	Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End	NASDAQ:CMRX	Chimerix Inc
2024/12/07	06 : 01	GlobeNewswire Inc.	Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:CMRX	Chimerix Inc
2024/11/15	06 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CMRX	Chimerix Inc
2024/11/11	21 : 00	GlobeNewswire Inc.	Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting	NASDAQ:CMRX	Chimerix Inc
2024/11/07	21 : 28	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CMRX	Chimerix Inc
2024/11/07	21 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CMRX	Chimerix Inc
2024/11/07	21 : 00	GlobeNewswire Inc.	Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational Update	NASDAQ:CMRX	Chimerix Inc
2024/11/01	20 : 00	GlobeNewswire Inc.	Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024	NASDAQ:CMRX	Chimerix Inc
2024/10/31	09 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CMRX	Chimerix Inc
2024/10/19	05 : 31	GlobeNewswire Inc.	Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:CMRX	Chimerix Inc
2024/09/03	20 : 00	GlobeNewswire Inc.	Chimerix to Present at H.C. Wainwright 26th Annual Global Investment Conference	NASDAQ:CMRX	Chimerix Inc